Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allergan Plc (ACT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allergan Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1578845.
Total stock buying since 2014: $8,918,208.
Total stock sales since 2014: $37,745,998.
Total stock option exercises since 2014: $10,935,326.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 1,760 | $252,413 | 0 | $0 | 0 | $0 |
| 2018 | 21,095 | $3,702,520 | 84,359 | $13,459,295 | 46,754 | $2,985,332 |
| 2017 | 17,715 | $2,911,709 | 83,696 | $19,766,549 | 171,189 | $5,430,051 |
| 2016 | 7,333 | $1,452,204 | 1,717 | $389,469 | 14,155 | $1,510,664 |
| 2015 | 2,000 | $599,362 | 4,500 | $1,375,166 | 4,500 | $371,385 |
| 2014 | 0 | $0 | 11,192 | $2,755,519 | 7,083 | $637,894 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-03 | 1,760 | $252,413 | 0 | $0 | 0 | $0 |
| 2018-11 | 1,000 | $157,000 | 0 | $0 | 0 | $0 |
| 2018-09 | 10,000 | $1,906,150 | 0 | $0 | 0 | $0 |
| 2018-08 | 2,000 | $381,290 | 1,055 | $200,502 | 1,889 | $153,311 |
| 2018-05 | 0 | $0 | 24,425 | $3,775,860 | 21,252 | $1,447,473 |
| 2018-03 | 6,095 | $936,200 | 0 | $0 | 0 | $0 |
| 2018-02 | 2,000 | $321,880 | 58,879 | $9,482,933 | 23,613 | $1,384,548 |
| 2017-12 | 17,630 | $2,891,391 | 11,807 | $2,053,119 | 11,807 | $931,336 |
| 2017-10 | 0 | $0 | 0 | $0 | 139,800 | $0 |
| 2017-06 | 43 | $10,146 | 0 | $0 | 0 | $0 |
| 2017-05 | 0 | $0 | 1,889 | $416,430 | 19,582 | $4,498,715 |
| 2017-03 | 42 | $10,172 | 70,000 | $17,297,000 | 0 | $0 |
| 2016-12 | 0 | $0 | 500 | $94,360 | 11,807 | $1,288,379 |
| 2016-11 | 6,672 | $1,292,527 | 0 | $0 | 0 | $0 |
| 2016-08 | 0 | $0 | 758 | $191,789 | 1,889 | $184,404 |
| 2016-06 | 661 | $159,677 | 0 | $0 | 0 | $0 |
| 2016-05 | 0 | $0 | 459 | $103,320 | 459 | $37,881 |
| 2015-12 | 0 | $0 | 2,300 | $719,808 | 2,300 | $189,819 |
| 2015-08 | 2,000 | $599,362 | 0 | $0 | 0 | $0 |
| 2015-06 | 0 | $0 | 2,200 | $655,358 | 2,200 | $181,566 |
| 2014-11 | 0 | $0 | 4,550 | $1,224,605 | 7,083 | $637,894 |
| 2014-09 | 0 | $0 | 6,642 | $1,530,914 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-07 | Saunders Brent L (Chairman, President and CEO) | Buy | 1,760 | 143.42 | 252,413 |
| 2018-11-16 | Walsh Matthew M (EVP, Chief Financial Officer) | Buy | 1,000 | 157.00 | 157,000 |
| 2018-09-06 | Coughlin Christopher J | Buy | 10,000 | 190.62 | 1,906,150 |
| 2018-08-30 | Boccuzi Joseph H | Buy | 900 | 190.59 | 171,531 |
| 2018-08-30 | Basgoz Nesli | Sale | 1,055 | 190.05 | 200,502 |
| 2018-08-30 | Freyman Thomas C | Buy | 1,100 | 190.69 | 209,759 |
| 2018-08-10 | Basgoz Nesli | Option Ex | 1,889 | 81.16 | 153,311 |
| 2018-05-17 | Meury William (EVP & Chief Commercial Officer) | Sale | 24,425 | 154.59 | 3,775,860 |
| 2018-05-17 | Meury William (EVP & Chief Commercial Officer) | Option Ex | 21,252 | 68.11 | 1,447,473 |
| 2018-03-15 | Hilado Maria Teresa (Executive Vice President) | Buy | 895 | 167.39 | 149,814 |
| 2018-03-08 | Walsh Matthew M (EVP, Chief Financial Officer) | Buy | 1,000 | 153.96 | 153,960 |
| 2018-03-08 | Saunders Brent L (Chairman, President and CEO) | Buy | 3,300 | 152.53 | 503,349 |
| 2018-03-05 | Boccuzi Joseph H | Buy | 900 | 143.42 | 129,077 |
| 2018-02-21 | Walsh Matthew M (EVP, Chief Financial Officer) | Buy | 2,000 | 160.94 | 321,880 |
| 2018-02-14 | Meury William (Chief Commercial Officer) | Sale | 58,879 | 161.06 | 9,482,933 |
| 2018-02-14 | Meury William (Chief Commercial Officer) | Option Ex | 23,613 | 58.63 | 1,384,548 |
| 2017-12-07 | Bodine Chris W | Buy | 3,030 | 164.77 | 499,253 |
| 2017-12-06 | Saunders Brent L (Chairman, President and CEO) | Buy | 4,600 | 165.03 | 759,138 |
| 2017-12-05 | Coughlin Christopher J | Buy | 10,000 | 163.30 | 1,633,000 |
| 2017-12-01 | Meury William (Chief Commercial Officer) | Sale | 11,807 | 173.89 | 2,053,119 |
| 2017-12-01 | Meury William (Chief Commercial Officer) | Option Ex | 11,807 | 78.88 | 931,336 |
| 2017-10-26 | Nicholson C. David (Chief R&D Officer) | Option Ex | 6,274 | .00 | 0 |
| 2017-10-26 | Ling Karen (Chief Human Resources Officer) | Option Ex | 7,545 | .00 | 0 |
| 2017-10-26 | Bailey A Robert D (Chief Legal Officer & Corp Sec) | Option Ex | 7,988 | .00 | 0 |
| 2017-10-26 | Hilado Maria Teresa (Chief Financial Officer) | Option Ex | 7,120 | .00 | 0 |
| 2017-10-26 | Darecca James (CHIEF ACCOUNTING OFFICER) | Option Ex | 799 | .00 | 0 |
| 2017-10-26 | Meury William (Chief Commercial Officer) | Option Ex | 9,321 | .00 | 0 |
| 2017-10-26 | Stewart Robert A (Chief Operating Officer) | Option Ex | 12,427 | .00 | 0 |
| 2017-10-26 | Saunders Brent L (Chairman, President and CEO) | Option Ex | 50,599 | .00 | 0 |
| 2017-10-26 | Bisaro Paul | Option Ex | 37,727 | .00 | 0 |
| 2017-06-16 | Saunders Brent L (Chairman, President and CEO) | Buy | 43 | 235.96 | 10,146 |
| 2017-05-18 | Basgoz Nesli | Sale | 1,889 | 220.45 | 416,430 |
| 2017-05-18 | Basgoz Nesli | Option Ex | 1,889 | 84.44 | 159,507 |
| 2017-05-04 | Gallagher Michael R | Option Ex | 17,693 | 245.25 | 4,339,208 |
| 2017-03-29 | Saunders Brent L (Chairman, President and CEO) | Buy | 42 | 242.21 | 10,172 |
| 2017-03-02 | Bisaro Paul | Sale | 70,000 | 247.10 | 17,297,000 |
| 2016-12-08 | Meury William (Chief Commercial Officer) | Option Ex | 11,807 | 109.12 | 1,288,379 |
| 2016-12-08 | Basgoz Nesli | Sale | 500 | 188.72 | 94,360 |
| 2016-11-21 | Saunders Brent L (CEO and President) | Buy | 5,250 | 189.13 | 992,943 |
| 2016-11-11 | Hilado Maria Teresa (Chief Financial Officer) | Buy | 1,422 | 210.68 | 299,584 |
| 2016-08-05 | Basgoz Nesli | Sale | 758 | 253.02 | 191,789 |
| 2016-08-05 | Basgoz Nesli | Option Ex | 1,889 | 97.62 | 184,404 |
| 2016-06-02 | Hilado Maria Teresa (Chief Financial Officer) | Buy | 661 | 241.57 | 159,677 |
| 2016-05-11 | Basgoz Nesli | Sale | 459 | 225.10 | 103,320 |
| 2016-05-11 | Basgoz Nesli | Option Ex | 459 | 82.53 | 37,881 |
| 2015-12-07 | Basgoz Nesli | Sale | 2,300 | 312.96 | 719,808 |
| 2015-12-07 | Basgoz Nesli | Option Ex | 2,300 | 82.53 | 189,819 |
| 2015-08-24 | Bisaro Paul (Exec Chairman) | Buy | 1,000 | 297.42 | 297,422 |
| 2015-08-21 | Saunders Brent L (CEO and President) | Buy | 1,000 | 301.94 | 301,940 |
| 2015-06-09 | Basgoz Nesli | Sale | 2,200 | 297.89 | 655,358 |
| 2015-06-09 | Basgoz Nesli | Option Ex | 2,200 | 82.53 | 181,566 |
| 2014-11-26 | Meury William (See Remarks) | Sale | 4,550 | 269.14 | 1,224,605 |
| 2014-11-26 | Meury William (See Remarks) | Option Ex | 7,083 | 90.06 | 637,894 |
| 2014-09-08 | Paonessa Albert Iii (President Anda, Inc.) | Sale | 6,642 | 230.49 | 1,530,914 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allergan Plc (symbol ACT, CIK number 1578845) see the Securities and Exchange Commission (SEC) website.